<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04028193</url>
  </required_header>
  <id_info>
    <org_study_id>5411069DD0467</org_study_id>
    <nct_id>NCT04028193</nct_id>
  </id_info>
  <brief_title>Fat Supplementation on Dumping Syndrome Associated Symptoms</brief_title>
  <acronym>Fat on DS</acronym>
  <official_title>The Effect of Fat Supplementation on the Appearance of Symptoms Associated With Dumping Syndrome in Patients Undergone Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technological Educational Institute of Thessaly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technological Educational Institute of Thessaly</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is the investigation of the effect of fat supplement on gastric
      emptying rate and the appearance of symptoms of Dumping Syndrome in patients who have
      undergone gastrointestinal- duodenal surgery. Patients who have undergone bariatric surgery
      have been examined for the presence of the Dumping syndrome, with glucose measurements, the
      Sigstad's questionnaire and questionnaire of Arts. Patients diagnosed positive, reiterated
      the examination process in a second meeting consuming an extra fat supplement. The data
      obtained on the different appointments were compared between the two groups in a cross over
      design.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 12, 2017</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose Levels</measure>
    <time_frame>before the ingestion of the carbohydrate and fat supplement (baseline)</time_frame>
    <description>Blood glucose measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Levels</measure>
    <time_frame>30 minutes after the ingestion of the carbohydrate and fat supplement</time_frame>
    <description>Blood glucose measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Levels</measure>
    <time_frame>60 minutes after the ingestion of the the carbohydrate and fat supplement</time_frame>
    <description>Blood glucose measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Levels</measure>
    <time_frame>90 minutes after the ingestion of the the carbohydrate and fat supplement</time_frame>
    <description>Blood glucose measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Levels</measure>
    <time_frame>120 minutes after the ingestion of the the carbohydrate and fat supplement</time_frame>
    <description>Blood glucose measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sigstad's Questionnaire</measure>
    <time_frame>1st hour after the ingestion of the supplements</time_frame>
    <description>Dumping syndrome symptom associated questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sigstad's Questionnaire</measure>
    <time_frame>2nd hour after the ingestion of the supplements</time_frame>
    <description>Dumping syndrome symptom associated questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arts's Questionnaire</measure>
    <time_frame>1st hour after the ingestion of the supplements</time_frame>
    <description>Dumping syndrome symptom associated questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arts's Questionnaire</measure>
    <time_frame>2nd hour after the ingestion of the supplements</time_frame>
    <description>Dumping syndrome symptom associated questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Dumping Syndrome</condition>
  <arm_group>
    <arm_group_label>Diagnose Dumping after supplement consumption</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Carbohydrate ingestion to provoke dumping syndrome related symptoms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fat supplementation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A high fat supplement was added to the carbohydrate liquid meal that was previously used for diagnosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calogen</intervention_name>
    <description>Polyunsaturated liquid fat supplement</description>
    <arm_group_label>Fat supplementation</arm_group_label>
    <other_name>Calogen fat supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resource Energy</intervention_name>
    <description>Carbohydrate Supplement</description>
    <arm_group_label>Diagnose Dumping after supplement consumption</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Dumping Syndrome

        Exclusion Criteria:

          -  Patients with diabetes mellitus type 1 and 2, Patients with impaired balance of fluids
             and electrolytes, Patients on diuretics pills or corticosteroids or hypoglycemic
             tablets and Insulin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>NIKOLETA CHATZIPAPA</last_name>
    <phone>00306982484394</phone>
    <email>nikoletaxatzhpapa@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DEMETRA HARITOU</last_name>
    <phone>00306973240203</phone>
    <email>dharitou@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nikoleta Chatzipapa</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56533</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NIKOLETA CHATZIPAPA</last_name>
      <email>nikoletaxatzhpapa@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>DEMETRA HARITOU</last_name>
      <email>dharitou@yahoo.gr</email>
    </contact_backup>
    <investigator>
      <last_name>Demetra Haritou</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikoleta Chatzipapa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 15, 2019</study_first_submitted>
  <study_first_submitted_qc>July 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2019</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Thessaly</investigator_affiliation>
    <investigator_full_name>Chatzipapa Nikoleta</investigator_full_name>
    <investigator_title>Research Associate University of Thessaly</investigator_title>
  </responsible_party>
  <keyword>Dumping syndrome</keyword>
  <keyword>Fat supplement</keyword>
  <keyword>post bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dumping Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

